Richard Alexander Collins (Director) sold ~$172K of Dexcom
Scheduled in advanceLoading…
Traded Nov 10, 2025 · Filed Nov 11, 2025
A Dexcom director sold $218K of Dexcom shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$217,811
Shares × reported transaction price
11 days after results of Oct 30, 2025, 63 days before results of Jan 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $54.84 on Nov 10, 2025, at its 52-week low, after a 17% drop over the previous 30 trading days
52-week range $54.84 (Nov 10, 2025) to $90.75 (Feb 24, 2025), 0% of the way up, from 250 adjusted closes. 30 trading days earlier: $66.46 on Sep 29, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Nov 10, 2025 in the U.S. District Court, S.D. New York. A filing is an allegation, not a finding.
5 such cases were open. Oakland County Employees Retirement System v. DexCom, Inc., docket 1:25-cv-09370, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.5% | −3.4% | +6.9% |
| 30 days | +18.6% | +0.9% | +17.7% |
| 90 days | +20.7% | +1.6% | +19.1% |
| 180 days | +2.1% | +8.2% | −6.2% |
Past results only. Not a forecast.
Richard Alexander Collins (Director) sold ~$172K of Dexcom
Scheduled in advanceBridgette P Heller (Director) sold ~$59K of Dexcom
Scheduled in advanceTraded Nov 10, 2025 · filed 1 day later
Dexcom's President & COO paid $863K out of pocket for Dexcom shares. The Dexcom shares held grew by 5%.